06/06/2014 - 12:18pm

The Centers for Disease Control and Prevention recently updated a health advisory, recommending an inactivated poliovirus booster for adults traveling to countries with an active wild polio virus in circulation.

06/06/2014 - 11:17am

Teva Pharmaceuticals announced the launch of Mimvey Lo (estradiol and norethindrone acetate tablets, USP), the generic equivalent to Activella tablets.

06/06/2014 - 10:43am

Health Media Network and the American College of Cardiology on Wednesday announced a strategic partnership that will significantly increase the size of HMN's Cardiology Network while broadening the distribution of ACC's CardioSmart Initiative.

06/04/2014 - 12:17pm

Ron Chapman, director of the California Department of Public Health and state health officer, last week warned that the number of pertussis (whooping cough) cases continue to increase in California.

06/04/2014 - 10:19am

Cardinal Health on Wednesday launched a new solution to make it easier and more time-efficient for retail pharmacies to help patients better understand and adhere to their medications.

06/03/2014 - 2:42pm

Indian drug maker Wockhardt has been charged by the Food and Drug Administration with utilizing the same unapproved method to test drug quality in its Morton Grove, Ill., facility as two facilities in India, both of which were subsequently banned from importing into the United States,the Wall Street Journal reported Tuesday.

06/03/2014 - 10:50am

Sandoz on Tuesday announced an agreement with Upsher-Smith to obtain exclusive U.S. distribution rights for its branded potassium chloride line of products, Klor-Con, and market them under the Sandoz name.

06/03/2014 - 9:45am

HDMA on Tuesday honored pharmaceutical and consumer product manufacturers at its 2014 Business and Leadership Conference in Phoenix, through the presentation of the Association’s annual Distribution Industry Awards for Notable Achievements in Healthcare (the DIANA awards).

06/03/2014 - 9:03am

Actavis last week announced that it has reached an agreement with Cephalon to settle all outstanding patent litigation associated with Actavis' generic version of Nuvigil (armodafinil tablets).